"Antitubercular Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.
| Descriptor ID |
D000995
|
| MeSH Number(s) |
D27.505.954.122.085.255
|
| Concept/Terms |
Antitubercular Agents- Antitubercular Agents
- Agents, Antitubercular
- Antitubercular Drugs
- Drugs, Antitubercular
- Tuberculostatic Agents
- Agents, Tuberculostatic
|
Below are MeSH descriptors whose meaning is more general than "Antitubercular Agents".
Below are MeSH descriptors whose meaning is more specific than "Antitubercular Agents".
This graph shows the total number of publications written about "Antitubercular Agents" by people in this website by year, and whether "Antitubercular Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 2 | 1 | 3 |
| 2006 | 0 | 1 | 1 |
| 2007 | 2 | 1 | 3 |
| 2008 | 1 | 1 | 2 |
| 2009 | 2 | 1 | 3 |
| 2010 | 3 | 1 | 4 |
| 2011 | 4 | 2 | 6 |
| 2012 | 2 | 2 | 4 |
| 2013 | 3 | 0 | 3 |
| 2014 | 2 | 0 | 2 |
| 2015 | 1 | 1 | 2 |
| 2016 | 7 | 4 | 11 |
| 2017 | 111 | 58 | 169 |
| 2018 | 77 | 55 | 132 |
| 2019 | 33 | 24 | 57 |
| 2020 | 0 | 8 | 8 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Antitubercular Agents" by people in Profiles.
-
Editorial: Updates from the World Health Organization (WHO) on Global Treatment Recommendations for Drug-Susceptible and Multidrug-Resistant Tuberculosis. Med Sci Monit. 2021 Aug 09; 27:e934292.
-
Spontaneous pneumothoraces complicating acute miliary tuberculosis in a child having recent coronavirus disease 2019. J Postgrad Med. 2021 Jul-Sep; 67(3):177-179.
-
Situational analysis of 10 countries with a high burden of drug-resistant tuberculosis 2 years post-UNHLM declaration: progress and setbacks in a changing landscape. Int J Infect Dis. 2021 Jul; 108:557-567.
-
A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients. Int J Tuberc Lung Dis. 2021 May 01; 25(5):409-412.
-
Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis. Int J Mol Sci. 2021 Apr 06; 22(7).
-
Imaging as an alternate diagnostic modality in a presumptive case of abdominopelvic TB in a COVID-19 patient. BMJ Case Rep. 2021 Mar 02; 14(3).
-
Tuberculosis preventive therapy for children and adolescents: an emergency response to the COVID-19 pandemic. Lancet Child Adolesc Health. 2021 03; 5(3):159-161.
-
New tuberculosis tests and drugs remain out of reach. Lancet Infect Dis. 2021 02; 21(2):174.
-
Pulmonary tuberculosis masquerading as coronavirus disease 2019 in an HIV-infected individual with advanced immune suppression. AIDS. 2020 12 01; 34(15):2165-2168.
-
Impact of COVID-19 Pandemic on the National PPM Tuberculosis Control Project in Korea: the Korean PPM Monitoring Database between July 2019 and June 2020. J Korean Med Sci. 2020 Nov 09; 35(43):e388.